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Sepsis still causes death, often through cardiac failure and mitochondrial dysfunction. Dietary ω3 polyunsaturated fatty acids are
known to protect against cardiac dysfunction and sepsis lethality. This study set out to determine whether early low-severity
sepsis alters the cardiac mitochondrial function in animals fed a Western-type diet and whether dietary eicosapentaenoic acid
(EPA) administration protects the myocardium against the deleterious eﬀects of sepsis and if so to seek possible
mechanisms for its eﬀects. Rats were divided into two groups fed either an ω3 PUFA-deﬁcient diet (“Western diet,” DEF group)
or an EPA-enriched diet (EPA group) for 5 weeks. Each group was subdivided into two subgroups: sham-operated rats and rats
subjected to cecal ligation and puncture (CLP). In vivo cardiac mechanical function was examined, and mitochondria were
harvested to determine their functional activity. Oxidative stress was evaluated together with several factors involved in the
regulation of reactive oxygen species metabolism. Sepsis had little eﬀect on cardiac mechanical function but strongly depressed
mitochondrial function in the DEF group. Conversely, dietary EPA greatly protected the mitochondria through a decreased
oxidative stress of the mitochondrial matrix. The latter was probably due to an increased uncoupling protein-3 expression,
already seen in the sham-operated animals. CLP rats in the EPA group also displayed increased mitochondrial sirtuin-3 protein
expression that could reinforce the upholding of oxidative phosphorylation. Dietary EPA preconditioned the heart against
septic damage through several modiﬁcations that protect mitochondrial integrity. This preconditioning can explain the
cardioprotective eﬀect of dietary EPA during sepsis.
1. Introduction
Sepsis, due to bacterial contamination, aﬀects 30 million peo-
ple every year and is a leading cause of lethality worldwide,
with some 6 million annual deaths [1]. Owing to poorer
hygiene, the incidence of sepsis is higher in low- and
middle-income countries, with a particular risk for people
with vulnerable immune systems (neonates, elderly persons,
pregnant women, hospitalized persons, and patients with
AIDS, liver cirrhosis, cancer, kidney disease, diabetes, etc.).
However, sepsis is also very frequent in industrialized coun-
tries and is a cost burden on their healthcare systems when
it evolves toward septic shock [2].
Septic shock has been deﬁned by Bone [3] as sepsis with
persistent hypotension (systolic arterial pressure lower than
90mmHg) despite adequate vascular ﬁlling, associated with
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abnormal tissue perfusion (lactic acidosis, oliguria, and dis-
turbed consciousness). It is often observed in the course of
resistance to antibiotic therapy and triggers life-threatening
multiorgan dysfunctions. In 2010, approximately 15% of
French patients diagnosed with sepsis developed septic
shock, and even though the incidence of mortality has grad-
ually decreased with new therapeutic advances, it remains
high, with a rate of 39.5% [4]. Of the survivors, 42% of
patients displayed at least one comorbidity. Importantly,
cardiac failure accounts for approximately 50% of deaths
[5], the heart being one of the preferred targets of the infec-
tion. However, except for a stimulation of the heart rate
occurring in the early phase of sepsis [6], changes in cardiac
mechanical function are detected only in the sickest patients
using the most recent techniques (echography, MRI): they
are ﬁrst characterized by an impaired diastolic function,
which evolves toward a reduced systolic function in the most
severe cases [7, 8].
Therapeutic approaches must be applied soon after sepsis
is triggered, with little knowledge of the subsequent disease
severity. Determination of cardiac function is not an accurate
way to estimate illness seriousness. It would be useful to have
a cardiac parameter that is rapidly aﬀected even in low-
severity sepsis; a chosen therapy could then be appraised by
how eﬃciently it upheld this parameter in physiological
ranges.
The most recent hypothesis that oﬀered to explain the
cardiac disturbances encountered in sepsis involves bacterial
lipopolysaccharides. These bind to Toll-like receptors which
activate the NF-κB pathway. NF-κB migrates to the nucleus
and triggers an acute inﬂammatory response. The cytokines
released, mainly tumor necrosis factor-α (TNF-α) and inter-
leukin-1β (IL-1β), depress mitochondrial function through a
mechanism that involves severe oxidative stress and possibly
calcium overload [9]. The oxidative stress inhibits energy
production through suppression of the Krebs cycle aconitase
[10] and reactivates the inﬂammatory response in a vicious
cycle [11]. This leads to opening of the permeability transi-
tion pore, deenergization of the mitochondria, hypocontrac-
tility [12, 13], and cell death through apoptosis and/or
necrosis [14, 15]. The mitochondria are deﬁnitely an impor-
tant target in the etiology of sepsis [16].
Omega-3 (ω3) polyunsaturated fatty acids (PUFAs) are
known to be cardioprotective in several pathophysiological
situations including ischemia/reperfusion [17, 18], hypertro-
phy [19], and cardiac arrhythmias [20] through preservation
of mitochondrial integrity [17, 18]. Eicosapentaenoic acid
(C20:5 n-3 or EPA) is the best known of these [21, 22].
Omega-3 fatty acids are scant in Western diet, which is too
rich in the proinﬂammatory ω6 PUFAs [23]. Animal studies
using ω3 PUFA supplements clearly show that these fatty
acids are protective during sepsis [24–26]. However, the
mechanism of this protection is not yet properly documented
and may involve the mitochondrial function.
This study set out to (i) determine whether the function
of cardiac mitochondria is prematurely modiﬁed—before
the occurrence of contractile dysfunctions—in early low-
severity sepsis induced by cecal ligation and puncture in rats
fed aWestern diet, (ii) ﬁnd out whether dietary eicosapentae-
noic acid (C20:5 n-3 or EPA) protects the integrity of these
organelles, and (iii) seek a potential mechanism responsible
for observed eﬀects. For this purpose, rats were fed either a
diet deﬁcient in ω3 PUFAs to model a typical Western diet
or one enriched with EPA. Several features of the myocardial
function were assessed: in vivo cardiac mechanical function,
mitochondrial metabolism (rates of oxygen consumption,
ATP production, and reactive oxygen release), fatty acid
composition of cardiac phospholipids, and several parameters
related to oxidative stress and inﬂammation. We hypothe-
sized that (i) early low-severity sepsis causes increased inﬂam-
mation and disruption of mitochondrial integrity in rats fed
the Western-type diet and (ii) dietary EPA protects cardiac
mitochondria through a decreased matrix oxidative stress
related to increased UCP3 and SIRT3 protein expressions.
2. Materials and Methods
2.1. Ethical Approval. All the experiments followed the
European Union recommendations for the care and use
of laboratory animals for experimental and scientiﬁc pur-
poses. All the animal work was approved by the local
board of ethics for animal experimentation (Comité
d’éthique pour l’expérimentation animale, Auvergne) and
notiﬁed to the research animal facility of our laboratory
(authorization no. APAFIS#2213-2016082409264678 v2).
The research complied with the ARRIVE guidelines on
animal research [27].
2.2. Experimental Rats and Diet. Forty 4-month-old female
Wistar rats (Janvier, Le Genest-Saint-Isle, France) were
maintained four per cage under controlled lighting, humid-
ity, and temperature conditions. After one week of acclimati-
zation, the rats were randomly allocated to two diet groups
for 4 weeks. Each diet contained (in % w/w) casein 20,
L-cysteine 0.3, lipid 5, starch 42.4, maltodextrin 12.7, sucrose
10, cellulose 5, a mineral mixture 3.5, a vitamin mixture 1,
and choline 0.1. The lipid fraction contained approximately
2.25% of linoleic acid (C18:2 ω6 or LA). The fatty acid com-
position of the two diets is presented in Table 1. The ﬁrst
group of rats was fed a ω3 PUFA-deﬁcient diet (DEF). In
the second group, 0.625% of the monounsaturated fatty acids
(MUFAs) was replaced by eicosapentaenoic acid (C20:5 ω3
or EPA) giving a ω6/ω3 PUFA ratio of 3.
2.3. Surgical Procedure. After the period of feeding, each diet
group was subdivided into two equal subgroups. In the ﬁrst
subgroup, the cecum was externalized from the abdominal
cavity and immediately repositioned (Sham subgroups); in
the second, the cecum was ligated and punctured to induce
sepsis (Sept subgroups). The cecal ligation and puncture
(CLP) was performed according to Toscano et al. [28].
Brieﬂy, the rats were anesthetized with isoﬂurane (induction
4%, maintenance 2%). After fur shaving, the external abdom-
inal wall was disinfected with alcoholic betadine and a hori-
zontal incision was made in the ventral wall at the level of
the cecum to reach the abdominal cavity. The cecum was
externalized and laid on the disinfected external abdominal
wall. The cecum was ligated at 1 cm from the apex of the
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organ to trigger low-intensity sepsis. Two perforations were
then made through the wall of the ligated cecum lining
0.5 cm apart on the upper face of the organ with a 20-gauge
needle. Soft pressure was applied to the ligated part of the
cecum to facilitate externalization of digesta on the outside
of the organ. The cecum was reinserted immediately after-
wards into the abdominal cavity, and buprenorphine
(0.05mg/kg of the body weight) was injected subcutaneously
into the neck. The peritoneum was then closed with 6.0 silk
sutures and the skin with sutures and metal clips. After the
operation, anesthesia was stopped and the rats were placed
one per cage in the animal facility where they woke 3–5min
after isoﬂurane withdrawal. The rats were then maintained
in their cage for 48 h. The same diets as those given just
before the surgical intervention were maintained during the
postsurgery period.
To ensure that sepsis was induced, cardiac contractility
was evaluated by MRI (see paragraph below). We observed
that CLP tended to stimulate myocardial contractility
(p = 0 08) similarly in both groups (cross-interaction
between the eﬀect of the diet and that of CLP = 0 99). This
indicates clearly that animals of both groups were in the
initial hyperdynamic phase of sepsis [6].
2.4. Cardiac MRI. At the end of the 48 h postsurgical period,
in vivo cardiac function and morphology were assessed by
nuclear magnetic resonance imaging (MRI). Anesthesia
was induced in an anesthetic box using 5% isoﬂurane in
a 30/70% air/oxygen mixture. The animals were then
positioned prone in a rat cradle (Equipement Vétérinaire
Minerve, Esternay, France) and maintained at 1.5–2% iso-
ﬂurane at 1 liter/minute air/oxygen ﬂow throughout the
MRI experiments. The cradle was designed for positioning
of the rat in the magnet. A tooth and ear bar secure system
was installed along with lines for the delivery and scavenging
of anesthetic gases, temperature control, and respiratory
and electrocardiogram (ECG) monitoring. Temperature
was maintained using a ﬂow of heated air through the cradle.
The ECG signal was not measured during cardiac imaging
but was recorded in a few animals before electrode with-
drawal and positioning in the magnet to estimate the heart
rate for retrospective image reconstruction.
During cardiac MRI, high-resolution cine magnetic reso-
nance imaging (cine-MRI) was carried out with a Bruker
117/16 BioSpec instrument equipped with an 11.7T
(500MHz) horizontal magnet interfaced with an Avance III
console running Paravision 6.0 software and a shielded
BGA 9S gradient (Bruker BioSpin, Ettlingen, Germany). A
72mm inner diameter quadrature volume coil (Bruker
BioSpin, Ettlingen, Germany) was used for radiofrequency
(RF) transmission and MRI signal reception. The MRI
protocol for assessing myocardial function was modeled
on the human short-axis left ventricular (LV) framework
[29]. The navigator-based self-gated fast low-angle shot
(IntraGate FLASH) bright blood sequence was used for cine
imaging of the heart. Ten to 12 contiguous 1mm slices were
acquired to cover the heart from the base to the apex.
For the image analysis, the navigator slice was positioned
parallel to the image slice, centered to the heart and crossing
the lungs to maximize its sensitivity to cardiorespiratory
movements. The imaging parameters were as follows: repeti-
tion time (TR)/echo time (TE) 6/2.5ms, ﬂip angle (FA) 8
degrees, ﬁeld of view (FOV) 5 × 5 cm, matrix 256 × 256,
and slice thickness 1mm. Four hundred repetitions were per-
formed during acquisition of the whole raw dataset, and 16
movie frames were reconstructed using the Bruker IntraGate
reconstruction algorithm, which was fed with the heart rate
value (~400 bpm) recorded prior to the MRI and the mean
animal respiratory frequency as estimated parameters.
Image analysis was performed using the free Segment
v2.1 R5960 software [30]. Images were ﬁrst converted into
DICOM format before loading into Segment software for
segmentation using the built-in “alternative left ventricular
tool” algorithm. For each rat, end-diastolic volume (EDV)
and end-systolic volume (ESV) were ﬁrst identiﬁed by the
global maximum andminimum left ventricle (LV) cavity vol-
umes, respectively, to make sure that all the slices were in
phase. Semiautomatic segmentation of the LV was then per-
formed as described elsewhere [31]. Brieﬂy, a point was ﬁrst
seeded in the center of the LV blood pool, from which the
algorithm ﬁts a deformable model that expands toward the
endocardial border to include the LV blood pool across the
various short-axis slices. Manual adjustments were per-
formed as required afterward mainly for the epicardial
border in general and for the endocardial border where
the papillary muscles appear separated from the myocar-
dium. Stroke volume (SV = EDV − ESV), ejection fraction
(EF = SV/EDV), and cardiac output (CO = SV × heart rate)
Table 1: Fatty acid composition of the diets (%).
DEF EPA
C14:0 0.1 0.1
C16:0 6.5 5.7
C18:0 2.7 3.0
C20:0 0.1 0.1
C24:0 0.1 0.1
SFAs 9.5 9.0
C16:1 ω7 0.1 0.1
C18:1 ω9 40.8 26.6
C18:1 ω7 0.9 0.8
C20:1 ω9 0.1 0.4
MUFAs 42.0 27.9
C18:2 ω6 47.1 44.7
C20:2 ω6 nd 0.2
C20:3 ω6 nd 0.1
C20:4 ω6 nd 0.8
ω6 PUFAs 48.1 46.9
C18:3 ω3 0.1 0.1
C20:4 ω3 nd 0.4
C20:5 ω3 nd 15.5
ω3 PUFAs 0.1 15.6
ω6/ω3 481 3
SFA: saturated fatty acid; MUFA: monounsaturated fatty acid; PUFA:
polyunsaturated fatty acid; nd: not detected.
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were calculated from the end-diastolic and end-systolic
volumes. The EDV time curve was then used to derive
the contraction and relaxation rates.
2.5. Preparation of Isolated Mitochondria. At the end of the
cardiac MRI, about 200mg of the apical heart was freeze
clamped in liquid nitrogen and stored at −80°C for later
analysis. The mitochondria were extracted as previously
described [17]. Atria and the remaining aorta were cut oﬀ
from the heart. The myocardium was shredded with scissors
in a cold isolation buﬀer A composed of mannitol 220mM,
sucrose 70mM, MOPS 5mM, and EGTA 2mM, pH 7.4 at
4°C, fatty acid-free serum albumin 0.2%. The shreds of the
myocardium were rinsed several times on a ﬁlter and homog-
enized with a Polytron blender (0.4 s, rheostat = 3) and a
Potter-Elvehjem tissue grinder containing 15ml of isolation
buﬀer A. After centrifuging (800 × g, 10min, 4°C), the super-
natant with subsarcolemmal mitochondria was kept in ice.
The pellet was resuspended in a cold isolation buﬀer B com-
posed of KCl 100mM, MOPS 50mM, and EGTA 2mM, pH
7.4 at 4°C, fatty acid-free serum albumin 0.2%. A protease
(subtilisin 0.02%) was added for 1min to digest myoﬁbrils
at ice temperature, and the whole was then homogenized
with a tissue grinder (300 rpm, 3 to 4 transitions). Immedi-
ately afterward, subtilisin action was stopped by adding isola-
tion buﬀer (30ml) and centrifuging (8000 × g, 10min, 4°C).
The supernatant was discarded and the pellet was resus-
pended in isolation buﬀer B. The homogenate was then
centrifuged (800 × g, 10min, 4°C), and the resulting superna-
tant with intermyoﬁbrillar mitochondria was collected and
ﬁltered with the other supernatant. Mitochondria were then
washed by centrifuging (8000 × g, 10min, 4°C). The pellet
of mitochondria was suspended in cold isolation buﬀer C
composed of KCl 100mM, MOPS 50mM, and EGTA
1mM, pH7.4 at 4°C, recentrifuged (8000 × g, 10min, 4°C),
and ﬁnally resuspended at a concentration of approx.
15mg/ml.
2.6. Respiration Measurements. The rate of mitochondrial
oxygen consumption was measured at 30°C in an incubation
chamber (Oxytherm OXYT1, Hansatech, King’s Lynn,
England) with a Clark-type O2 electrode ﬁlled with 1ml
of incubation medium (KCl 125mM, Tris-HCl 20mM,
KH2PO4 10mM, and EGTA 1mM, pH 7.2 at 30
°C, fatty
acid-free bovine serum albumin 0.15%). All measurements
were made using mitochondria (0.2mg of mitochondrial
protein/ml) incubatedwith either glutamate (5.5mM)-malate
(2.5mM), palmitoylcarnitine (20 μM)-malate (2.5mM), or
succinate (5.5mM)-rotenone (2μM) as substrates (state 2),
in the presence of ADP 100mM (state 3) and afterwards with
the addition of oligomycin 0.5μg/ml (state 4). The pH of each
substrate was strictly ﬁxed at 7.4 at 30°C. The incubation
medium was maintained at 30°C and constantly stirred with
a built-in electromagnetic stirrer and bar ﬂea. Coupling of
the oxidative phosphorylation was assessed by the state 3 to
state 4 respiration rate ratio, which measures the degree of
control exerted on oxidation by phosphorylation (respiratory
control ratio or RCR). Amplex® Red (1 μM) and horseradish
peroxidase (5U/ml) were added to the medium at the
beginning of the respiration measurement to maintain the
same experimental conditions as those used in the measure-
ment of H2O2 release.
2.7. Mitochondrial Reactive Oxygen Species Release. The rate
of mitochondrial reactive oxygen species release was evalu-
ated in the same conditions as the respiration measurements.
It followed the linear increase in ﬂuorescence (excitation at
560 nm and emission at 584nm) due to enzymatic oxidation
of Amplex® Red by H2O2 in the presence of horseradish
peroxidase modiﬁed to kinetically follow the rate of produc-
tion of reactive oxygen species by isolated mitochondria on
a ﬂuorometer (Xenius XC, SAFAS, Monaco). Reaction condi-
tions were 0.20mg of mitochondrial protein/ml, 5U/ml of
horseradish peroxidase, and 1 μM of Amplex® Red with the
same substrates and concentrations as in the respiration
measurements.
2.8. Gene Expression. Total RNA was extracted from 50mg of
heart powder using TRIzol® (Thermo Scientiﬁc) according to
the manufacturer’s instructions. Chloroform was added
(0.2ml/ml of TRIzol®), and samples were mixed and centri-
fuged for 15min at 12000 × g at 4°C. An aqueous phase con-
taining ribonucleic acid (RNA) was collected, mixed with
isopropanol to precipitate RNA, and centrifuged (12000 × g,
4°C, 15min). After centrifuging, the pellet was washed with
ethanol 70% (vol/vol), dried, and suspended in water. RNA
quantiﬁcation and integrity were veriﬁed by measuring the
ratio of optical densities at 260nm and 280nm and by agarose
gelmigration, respectively. cDNAswere synthesized from2μg
of total RNA using the High-Capacity cDNA Reverse
Transcription Kit from Applied Biosystems (Thermo Fisher
Scientiﬁc, Asnières-sur-Seine, France). The products of
reverse transcription were used for quantitative real-time
polymerase chain reaction (qRT-PCR) using speciﬁc primers
and Rotor-Gene SYBR Green PCR master mix on a
Rotor-Gene Q system (QIAGEN, Courtaboeuf, France).
Messenger RNA (mRNA) was quantiﬁed using the standard
curve of native cDNA and serial dilutions. The cardiac
mRNA expressions were determined for hypoxia-inducible
factor-1 (HIF-1), sirtuin-3 (SIRT3), cytosolic Cu-Zn super-
oxide dismutase (SOD1), mitochondrial manganese-
dependent superoxide dismutase (SOD2), interleukin-1β
(IL-1β), tumor necrosis factor-α (TNF-α), hexokinase 2
(HK2), phosphofructokinase-2 (PFK2), pyruvate kinase
muscle-type (PKm), M and H lactate dehydrogenases
(LDH M and H), and pyruvate dehydrogenase kinase 4
(PDK4). Primer sequences and PCR conditions are pre-
sented in Table 2. Some housekeeping genes were tested
(β-actin and hypoxanthine phosphoribosyltransferase);
β-actin was ﬁnally chosen for its intergroup stability.
2.9. Western Blot Analysis. Tissues were ground three times
in a mini bead beater in the presence of a lysis buﬀer
made of HEPES 50mM, sodium chloride 150mM, EDTA
10mM, anhydrous sodium tetrabasic pyrophosphate 10mM,
β-glycerophosphate 25mM, sodium ﬂuoride 100mM, and
anhydrous glycerol 1.086M supplemented with phosphatase
inhibitors (Sigma Aldrich, Saint-Quentin-Fallavier, France).
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Successive centrifugations were performed and the super-
natants were collected. Proteins were quantiﬁed using a
bicinchoninic acid assay kit (Thermo Fisher Scientiﬁc,
Asnières-sur-Seine, France). For protein immunoblotting,
25 μg of proteins was loaded for separation by SDS-PAGE
electrophoresis and transferred on PVDF membranes.
Membranes were then immunoblotted with the appropriate
antibody to detect the nuclear factor of the kappa light
polypeptide gene enhancer in B-cell inhibitor alpha (IκBα)
(1 : 1000, Cell Signaling #9242), voltage-dependent anion-
selective channel (VDAC) (1 : 1000, Cell Signaling #4866),
sirtuin-3 (SIRT3) (1 : 500, Santa Cruz #sc-365175), uncou-
pling protein-3 (UCP3) (1 : 200, Santa Cruz #sc-31387),
nitrosylated tyrosine (1 : 1000, Thermo Scientiﬁc #32-1900),
acetylated lysine (1 : 1000, Cell Signaling #9441), and per-
oxisome proliferator-activated receptor gamma coactivator
1-alpha (PGC-1α) (1 : 5000, Santa Cruz #sc-13067). Anti-
body binding was detected using HRP-conjugated secondary
antibodies and ECL Western blotting substrate (Thermo
Fisher Scientiﬁc, Asnières-sur-Seine, France). Immunoblots
were visualized using a chemiluminescence imaging system
(MF-ChemiBIS, DNR Bio-Imaging Systems, Jerusalem,
Israel) and quantiﬁed using Multi Gauge V3.2 software. For
detection of nitrosylated proteins, protein extraction was per-
formed according to the manufacturer’s instructions. Several
housekeeping proteins including α-tubulin (1 : 1000, Sigma
#8203) and GAPDH (0.2 μg/ml, Sigma #G9545) were tested,
but none was stable across the four subgroups. However,
protein densitometry to Ponceau red was stable. It was
thus decided to normalize all the relevant proteins with
this parameter.
2.10. Lipid Analysis. Total lipids were extracted from cardiac
tissues according to Folch et al. [32]. Lipid extracts (approx.
50mg) were prepared using 4ml chloroform-methanol
(2 : 1 v/v) and 1ml 0.9% NaCl. After phospholipid separation
on Sep-Pak cartridges, fatty acid methyl esters were pre-
pared and separated by gas chromatography as previously
described [33].
2.11. Cardiac Oxidative Stress. Mitochondrial SOD was
assayed using a commercially available kit (Bertin Pharma,
Montigny-le-Bretonneux, France).
2.12. Statistical Analysis. Results are presented as mean ±
SEM. The data underwent a two-way analysis of variance
(ANOVA) describing the eﬀects of the diets and of sepsis
and the cross-interaction between them. When necessary,
the means were compared using Fisher’s least signiﬁcant
diﬀerence (LSD) test. A probability lower than 0.05 was con-
sidered signiﬁcant. Statistical analysis was performed using
the NCSS 2007 software (NCSS LLC, Kaysville, UT).
3. Results
3.1. General Data. The body weights of the animals before
surgery were similar in the four subgroups (243 ± 5, 245 ± 7,
266 ± 7, and250 ± 7 g for theDEFSham,DEFSept,EPASham,
and EPA Sept, respectively). The surgery tended to decrease
these variables, but the observed changes were not signiﬁcant
(data not shown). Since a large part of the myocardium was
used for mitochondrial preparation, the heart weights of
these rats were not determined.
3.2. Fatty Acid Composition of Cardiac Phospholipids. The
fatty acid composition of membrane phospholipids plays a
crucial role in the regulation of cardiac and mitochondrial
function because of not only its involvement in prostanoid
synthesis but also its engagement in the modulation of
enzymatic activities through changes in membrane ﬂuidity.
The EPA-rich diet did not notably modify the propor-
tions of saturated fats in cardiac membranes (Table 3), but
it decreased those of the monounsaturated fatty acid
C18:1ω9 (−22% and −16% in the Sham and Sept subgroups,
p < 0 001). Although the proportions of total PUFAs were
unchanged, their proﬁle was considerably altered by the
diets. PUFAs of the ω6 series were reduced by the EPA-rich
diet (−19% and −22% for the Sham and Sept subgroups,
p < 0 001), and those of the ω3 family were correspond-
ingly increased (+124 and +145%, p < 0 001). Arachidonic
acid (ArA or C20:4ω6) and its ﬁrst metabolites (C22:4ω6
and C22:5ω6) were thus decreased, and EPA, C22:5ω3,
and C22:6ω3 were greatly increased (p < 0 001 for all the
comparisons).
Table 2: Real-time PCR primers used in this study.
Gene Sequence (5′-3′)
β-Actin
(F) TCTGTGTGGATTGGTGGCTCTA
(R) CTGCTTGCTGATCCACATCTG
HIF-1
(F) AAGCACTAGACAAAGCTCACCTG
(R) TTGACCATATCGCTGTCCAC
HK2
(F) GAGCTACCACGCACCCTAC
(R) CACCCTTACTCGGAGCACAC
HPRT
(F) TTGCTGACCTGCTGGATTAC
(R) AGTTGAGAGATCATCTCCAC
IL-1β
(F) CACCTTCTTTTCCTTCATCTTTG
(R) GTCGTTGCTTGTCTCTCCTTGTA
LDHH
(F) ACCCCGTGTCTACAATGGTG
(R) GGTTGATGACGCTGGTCAGT
LDHM
(F) TGAAGTCTCTGAACCCGCAG
(R) CGTATGCACTGTCAACCACC
PDK4
(F) CACACCTTCACCACATGCTC
(R) CGTGAATTGTCCATCACAGG
PFK2
(F) TTGCGAGGAAAGCAGTTTGC
(R) ACACGCCAGCATCAATCTCA
PKm
(F) GTCAATCCACAGACCCCCTG
(R) CCACTTGGTGAGCACTCCTG
SIRT3
(F) TGCTACTCATTCTTGGGACCTC
(R) CTGTACCGATTCAGACAAGCTG
SOD1
(F) CAGGACCTCATTTTAATCCTCAC
(R) TGCCCAGGTCTCCAACAT
SOD2
(F) CCGAGGAGAAGTACCACGAG
(R) GCTTGATAGCCTCCAGCAAC
TNF-α
(F) GCCTCTTCTCATTCCTGCTC
(R) GAGCCCATTTGGGAACTTCT
(F): forward; (R): reverse.
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Sepsis triggered certain modiﬁcations of the phospho-
lipid fatty acid proﬁle that aﬀected only PUFAs. In the DEF
group, the infectious disease reduced the ﬁrst metabolites of
ArA (−10% and −10% for C22:4ω6 and C22:5ω6, p < 0 05).
In the EPA group, the pathology increased the propor-
tion of total ω3 PUFAs, mainly C22:6ω3 (+11 and +13%,
p < 0 05).
3.3. Sepsis-Induced Myocardial Inﬂammation. Bacterial lipo-
polysaccharides link to Toll-like receptors and activate the
NF-κB pathway. This activation is characterized by the
release and degradation of IκBα as well as migration of the
NF-κBmoiety to the nucleus and induction of the proinﬂam-
matory cytokine expression. The reduction of IκBα was
determined in the myocardial tissues of the four subgroups
of animals (Figure 1(c)). Dietary EPA did not alter its
value in sham-operated animals but increased it after sep-
sis (+103%, p < 0 001) compared to Sept animals fed the
DEF diet.
Figure 1 also depicts the eﬀects of dietary EPA and sepsis
on cardiac TNF-α and IL-1β mRNA expressions. Gene
expression of TNF-α (Figure 1(d)) was not aﬀected by sepsis
but depended on the dietary PUFA ingested: it was signiﬁ-
cantly decreased by dietary EPA (−33% and −56% in the
Table 3: Fatty acid composition of cardiac phospholipids.
Fatty acid DEF Sham DEF Sept EPA Sham EPA Sept
C14:0 0 13 ± 0 03 0 11 ± 0 02 0 12 ± 0 01 0 10 ± 0 01
C15:0 0 15 ± 0 02 0 14 ± 0 02 0 14 ± 0 01 0 13 ± 0 02
C16:0 10 3 ± 0 2b 10 2 ± 0 4b 10 7 ± 0 4ab 11 2 ± 0 1a
C17:0 0 18 ± 0 01 0 18 ± 0 01 0 18 ± 0 01 0 18 ± 0 01
C18:0 22 3 ± 0 2 22 4 ± 0 1 22 2 ± 0 3 21 9 ± 0 1
C20:0 0 16 ± 0 01 0 15 ± 0 01 0 16 ± 0 01 0 16 ± 0 01
C22:0 0 27 ± 0 01 0 28 ± 0 02 0 27 ± 0 02 0 26 ± 0 02
C24:0 0 13 ± 0 01 0 14 ± 0 01 0 14 ± 0 01 0 14 ± 0 01
SFA 33 7 ± 0 3 33 7 ± 0 4 34 0 ± 0 2 34 2 ± 0 2
C16:1 ω7 0 20 ± 0 01 0 23 ± 0 02 0 21 ± 0 02 0 23 ± 0 01
C18:1 ω9 4 1 ± 0 2a 3 7 ± 0 1a 3 2 ± 0 1b 3 1 ± 0 2b
C18:1 ω7 2 8 ± 0 1 2 9 ± 0 1 2 6 ± 0 1 2 6 ± 0 1
trans-MUFA 0 18 ± 0 01 0 19 ± 0 01 0 20 ± 0 01 0 19 ± 0 01
C22:1 ω9 0 3 ± 0 1 0 2 ± 0 1 0 3 ± 0 1 0 2 ± 0 1
MUFA 7 6 ± 0 1a 7 3 ± 0 2a 6 7 ± 0 3b 6 4 ± 0 2b
C18:2 ω6 17 6 ± 0 5ab 17 4 ± 0 6a 19 0 ± 0 3b 18 5 ± 0 6ab
C20:2 ω6 0 18 ± 0 01 0 17 ± 0 01 0 16 ± 0 01 0 16 ± 0 01
C20:3 ω6 0 25 ± 0 01a 0 27 ± 0 01a 0 32 ± 0 01b 0 32 ± 0 01b
C20:4 ω6 22 5 ± 0 5a 23 3 ± 0 5a 18 6 ± 0 8b 17 3 ± 0 3b
C22:4 ω6 1 86 ± 0 08a 1 68 ± 0 05b 0 29 ± 0 02c 0 33 ± 0 02c
C22:5 ω6 5 1 ± 0 3a 4 6 ± 0 2b 0 2 ± 0 1c 0 1 ± 0 1c
ω6 PUFA 47 4 ± 0 6a 47 3 ± 0 7a 38 6 ± 0 8b 36 7 ± 0 4b
C18:4 ω3 0 08 ± 0 02a 0 14 ± 0 01b 0 11 ± 0 01ab 0 12 ± 0 02ab
C20:5 ω3 nda nda 0 79 ± 0 08b 0 77 ± 0 04b
C22:5 ω3 0 7 ± 0 1a 0 7 ± 0 1a 4 3 ± 0 3b 4 6 ± 0 1b
C22:6 ω3 6 6 ± 0 6a 6 6 ± 0 4a 11 4 ± 0 4b 12 9 ± 0 6c
ω3 PUFA 7 4 ± 0 6a 7 5 ± 0 4a 16 6 ± 0 6b 18 4 ± 0 5c
Total PUFA 54 8 ± 0 2 54 9 ± 0 4 55 2 ± 0 4 55 1 ± 0 3
ω6/ω3 6 6 ± 0 7a 6 4 ± 0 4a 2 4 ± 0 1b 2 0 ± 0 1b
The means correspond to the average of 5 rats. DEF Sham: rats fed the ω3 fatty acid-deﬁcient diet with ﬁctitious surgery; DEF Sept: rats fed the ω3 fatty
acid-deﬁcient diet with cecal ligation and puncture; EPA Sham: rats fed the EPA-rich diet with ﬁctitious surgery; EPA Sept: rats fed the EPA-rich diet with cecal
ligation and puncture; SFA: saturated fatty acids, MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; nd: not detected; a, b: means without
a common letter on each line are signiﬁcantly diﬀerent.
6 Oxidative Medicine and Cellular Longevity
Sham and Sept subgroups, p < 0 05 in general). IL-1βmRNA
expression (Figure 1(e)) behaved diﬀerently: it was consider-
ably increased by CLP in the DEF group (+530%, p < 0 01),
but not at all in the EPA group (−67%, NS, CI: p < 0 01).
3.4. MRI Study. The in vivo cardiac morphology and function
were determined by MRI (Table 4) to know whether these
parameters were sensitive enough to the eﬀects of the early
low-severity sepsis and EPA treatment. Cardiac morphology
estimated by the end-diastolic and end-systolic volumes was
minimally aﬀected by the diets and surgery. This was also the
case for the cardiac function parameters, including ejection
fraction, heart rate, cardiac output, and relaxation. However,
an interesting tendency was noted for contraction: sepsis
tended to increase the contraction rate in both diet groups
(+14% and +13% for the DEF and EPA groups, p = 0 085):
no diet eﬀect was noted, however.
3.5. Mitochondrial Function. Cardiac mitochondria were
immediately harvested after sacriﬁce to evaluate their energy
metabolism and reactive oxygen species release (Table 5) to
determine whether the function of these organelles was mod-
iﬁed by sepsis and dietary EPA. The main modiﬁcations were
observed when glutamate/malate was used as substrate. In
the DEF groups, sepsis reduced the state 3 respiration rate
(−42%, p < 0 01), respiratory control ratio (RCR) (−31%,
p < 0 01), and rate of ATP production (−37%, p < 0 05).
Although the basal rates of H2O2 release during states 3
and 4 of the respiration were unchanged, the ratios of
H2O2 release to the state 3 respiration rate and of H2O2
release to the rate of ATP production were greatly increased
by sepsis (+70 and +128%, respectively, p < 0 05). Interest-
ingly, none of these parameters (state 3 respiration rate,
RCR, H2O2 release/state 3 respiration rate, and H2O2
release/rate of ATP production) were altered by sepsis in
the EPA-fed rats.
When succinate/rotenone or palmitoylcarnitine/malate
was used as substrates, the same trends were observed for
the rates of state 3 respiration and ATP production but the
diﬀerences were not signiﬁcant. However, for the H2O2
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Figure 1: Cardiac inﬂammation parameters: (a) representative immunoblots of myocardial IκBα; (b) protein densitometry to Ponceau S of
the corresponding samples; (c) quantiﬁcation of myocardial IκBα; (d) TNF-αmRNA expression; (e) IL-1βmRNA expression. The means are
a consortium of 8 rats 48 h after the surgery. DEF: rats fed the ω3 polyunsaturated fatty acid-deﬁcient diet; EPA: rats fed the eicosapentaenoic
acid-enriched diet; Sham: sham-operated rats; Sept: septic rats; D: diet eﬀect; CI: cross-interaction between the eﬀect of the diet and that of
sepsis; A, B: histogram bars on the same panel without a common letter are signiﬁcantly diﬀerent.
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release normalized to the rates of state 3 respiration or ATP
production, the diﬀerences generally remained signiﬁcant
like those observed with glutamate/malate as substrates.
3.6. Glycolytic Enzyme mRNA Expressions. High glucose oxi-
dation and low fatty acid degradation are often associated
with a cardioprotective metabolic proﬁle [34, 35]. Table 6
summarizes the mRNA expression of several glycolytic
enzymes in order to estimate glucose metabolism. Sham-
operated rats fed the diﬀerent diets had the same glycolytic
enzyme mRNA expressions except for that of pyruvate
kinase, which was reduced by the EPA diet (−30%, p < 0 05
by one-way analysis of variance). Pyruvate dehydrogenase
kinase 4 gene expression was also decreased by the EPA diet
(−62%, p < 0 05 by one-way analysis of variance). Sepsis had
little eﬀect on the glycolytic enzyme mRNA expression in the
DEF diet-fed rats: it tended only to increase the hexokinase 2
gene expression (+41%, p = 0 058 by one-way analysis of var-
iance). Conversely, it strongly decreased the expression of
several enzymes in the EPA diet-fed rats: phosphofructoki-
nase 2 (−41%, p < 0 05), pyruvate kinase (−61%, p < 0 01),
and muscle (−37%, p < 0 01) and cardiac (−60%, p< 0.01)
lactate dehydrogenases. The hexokinase 2 and pyruvate
dehydrogenase kinase 4 mRNA expressions were also
decreased (−50% and 77%, respectively, p < 0 01 by one-
way analysis of variance). Mitochondrial acetylated lysine
reﬂects the rate of β-oxidation [36]. In sham-operated ani-
mals, acetylated lysine expression (Figure 2) was decreased
by dietary EPA (−66%, p < 0 001). Sepsis reduced lysine acet-
ylation in the DEF group (−48%, p < 0 01) but increased it in
the EPA group (+102%, p < 0 05).
3.7. Oxidative and Nitrosative Stresses. The oxidative stress
was further evaluated in the whole myocardium by deter-
mining SOD mRNA expressions. The cytosolic SOD1
(Figure 3(a)) was increased in the EPA subgroups (+58
and +54% for the Sham and Sept subgroups, p < 0 05 in
general) compared with the DEF subgroups but was not
aﬀected by sepsis. By contrast, the gene expression of the
mitochondrial SOD 2 (Figure 3(b)) was reduced by the
EPA-rich diet (−59%, p < 0 001) but this was signiﬁcant
only in the Sept subgroup (−76%, p < 0 001). This param-
eter was not aﬀected by sepsis in the DEF group. The total
mitochondrial SOD activity (Figure 3(c)) was not inﬂu-
enced by the diets but was increased by sepsis (+19% for
the DEF plus EPA groups, p < 0 05).
Nitrosylation intensity of mitochondrial proteins is pre-
sented in Figure 4. Sham-operated animals of the EPA group
displayed a lower degree of nitrosylation (−55%, p < 0 05)
than their counterparts fed the DEF diet. Sepsis reduced this
parameter in the DEF group (−26%) but increased it in the
EPA group (+51%, CI: p < 0 001). Finally, septic rats in the
EPA diet group displayed a higher degree of mitochondrial
protein nitrosylation (+54%, p < 0 01) than the DEF-fed rats.
3.8. HIF-1 and SIRT-3 Gene Expressions. Reactive oxygen
species (ROS) in the mitochondrial matrix are known to reg-
ulate the expressions of hypoxia-inducible factor-1 (HIF-1)
and sirtuin-3 (SIRT3) [37]. Since mitochondria of the DEF
group seemed to overproduce ROS, the gene expressions of
these two proteins were thus evaluated in the whole myocar-
dium. HIF-1 mRNA expression (Figure 5(a)) was aﬀected by
both the diet and the type of surgery. The presence of
EPA in the diet strongly reduced the gene expression of
this parameter (−40% and −44% for the Sham and Sept
subgroups, p < 0 01). Sepsis had also a lowering eﬀect
(−29% and −33% for the DEF and EPA groups, p < 0 05).
SIRT3mRNA expression (Figure 5(b)) evolved diﬀerently
with an increasing eﬀect of dietary EPA (+61 and+51% for the
Sham and Sept subgroups, p < 0 05) and no signiﬁcant inﬂu-
ence of sepsis.
3.9. Mitochondrial Uncoupling Protein-3 (UCP3), Sirtuin-3
(SIRT3), and Myocardial Voltage-Dependent Anion Channel
(VDAC) Expressions.UCP3 is known to modulate mitochon-
drial oxidative and nitrosative stresses [38]. Figure 6(c) shows
UCP3 expression in the mitochondria. Dietary EPA greatly
increased the expression of this protein irrespective of the
surgery (+207%, p < 0 05). Sepsis did not inﬂuence the
expression of this protein.
Table 4: In vivo cardiac morphology and function.
DEF Sham DEF Sept EPA Sham EPA Sept ANOVA
EDV 298 ± 26 326 ± 20 347 ± 27 306 ± 20
ESV 92 ± 8 113 ± 8 119 ± 15 95 ± 9 CI: p < 0 05
SEV 194 ± 16 231 ± 13 228 ± 16 211 ± 14
EF 65 ± 2 65 ± 4 66 ± 3 69 ± 2
HR 371 ± 6 366 ± 12 355 ± 7 374 ± 8
CO 229 ± 6 217 ± 24 227 ± 7 236 ± 11
CR 0 22 ± 0 02 0 25 ± 0 01 0 23 ± 0 02 0 26 ± 0 02 S: p = 0 085
RR 0 18 ± 0 01 0 17 ± 0 01 0 19 ± 0 02 0 19 ± 0 02
Themeans represent the average of 8 rats. DEF Sham: rats fed theω3 fatty acid-deﬁcient diet with ﬁctitious surgery; DEF Sept: rats fed theω3 fatty acid-deﬁcient
diet with cecal ligation and puncture; EPA Sham: rats fed the EPA-rich diet with ﬁctitious surgery; EPA Sept: rats fed the EPA-rich diet with cecal ligation and
puncture; EDV: end-diastolic volume (μl); ESV: end-systolic volume (μl); SEV: systolic ejection volume (μl/beat); EF: ejection fraction (%); HR: heart rate
(beats/min); CO: cardiac output (ml/min/g of wet weight); CR: contraction rate (cm2/s); RR: rate of relaxation (cm2/s); ANOVA: analysis of variance. The
two-way analysis of variance describes the eﬀects of the diets, those of sepsis (S), and the cross-interaction between these two factors (CI).
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Mitochondrial sirtuin-3 protein expression (Figure 6(f))
was inﬂuenced by the diet and type of surgery. In the
sham-operated subgroups, its content was lower when the
diet was enriched with EPA (−39%, p < 0 05). Sepsis induced
opposite eﬀects on this parameter according to the dietary
conditions (CI: p < 0 05). To examine this signiﬁcant cross-
interaction more closely, a one-way analysis of variance
describing the eﬀect of sepsis was performed in each dietary
group: in the DEF group, the eﬀect of sepsis was not signiﬁ-
cant (−25%, NS), but in the EPA group, sepsis signiﬁcantly
increased the amount of the protein (+60%, p < 0 05).
The myocardial content of mitochondria was evaluated
by estimating the protein content of the mitochondrial
voltage-dependent anion channel (VDAC) in the whole
Table 5: Mitochondrial function.
Substrate Parameter DEF Sham DEF Sept EPA Sham EPA Sept
GM
State 3 84 ± 7a 49 ± 7b 67 ± 5ab 87 ± 6a
State 4 13 ± 1a 10 ± 1a 11 ± 1ab 15 ± 1a
RCR 6 5 ± 0 2a 4 5 ± 0 5b 6 3 ± 0 2a 6 0 ± 0 1a
ATP 379 ± 49a 239 ± 58b 411 ± 47a 416 ± 35a
ATP/O 2 3 ± 0 2 2 6 ± 0 6 3 1 ± 0 3 2 4 ± 0 2
ROS state 3 81 ± 5 87 ± 7 79 ± 9 80 ± 7
ROS state 4 113 ± 7 123 ± 12 126 ± 18 119 ± 14
ROS/state 3 1 0 ± 0 1a 1 7 ± 0 2b 1 1 ± 0 2a 0 9 ± 0 1a
ROS/state 4 9 7 ± 0 9ab 12 6 ± 2 1a 10 8 ± 0 8ab 8 4 ± 1 0b
ROS/ATP 0 25 ± 0 04a 0 57 ± 0 18b 0 21 ± 0 03a 0 20 ± 0 03a
SR
State 3 129 ± 13 101 ± 13 120 ± 12 137 ± 16
State 4 52 ± 3 46 ± 4 49 ± 3 46 ± 2
RCR 2 5 ± 0 1 2 2 ± 0 1 2 5 ± 0 1 2 7 ± 0 2
ATP 293 ± 42ab 208 ± 33b 321 ± 21a 290 ± 19ab
ATP/O 1 1 ± 0 1 1 1 ± 0 1 1 3 ± 0 1 1 2 ± 0 1
ROS state 3 139 ± 6 146 ± 6 140 ± 6 143 ± 8
ROS state 4 174 ± 7 175 ± 11 173 ± 10 181 ± 15
ROS/state 3 1 2 ± 0 1a 1 6 ± 0 2b 1 2 ± 0 1a 1 1 ± 0 1a
ROS/state 4 3 4 ± 0 2 3 9 ± 0 3 3 4 ± 0 1 3 3 ± 0 1
ROS/ATP 0 60 ± 0 13ab 0 82 ± 0 13a 0 44 ± 0 03b 0 48 ± 0 02b
PM
State 3 111 ± 10 93 ± 14 124 ± 14 129 ± 15
State 4 12 ± 1 11 ± 2 10 ± 1 11 ± 1
RCR 9 1 ± 0 4a 8 6 ± 0 9a 13 ± 1b 12 ± 1b
ATP 616 ± 69 507 ± 103 621 ± 68 656 ± 46
ATP/O 2 6 ± 0 2 2 6 ± 0 3 2 6 ± 0 35 2 73 ± 0 2
ROS state 3 56 ± 5 57 ± 7 64 ± 11 59 ± 8
ROS state 4 90 ± 9 88 ± 11 98 ± 17 82 ± 8
ROS/state 3 0 5 ± 0 1a 0 7 ± 0 1b 0 5 ± 0 1a 0 5 ± 0 1a
ROS/state 4 7 6 ± 0 8 8 3 ± 1 0 9 8 ± 1 2 8 2 ± 0 9
ROS/ATP 0 10 ± 0 02ab 0 14 ± 0 03c 0 10 ± 0 01ac 0 09 ± 0 01ab
The means correspond to the average of 8 animals. DEF Sham: animals fed the ω3 fatty acid-deﬁcient diet with the ﬁctitious surgery; DEF Sept: animals fed the
ω3 fatty acid-deﬁcient diet with the cecal ligation and puncture; EPA Sham: animals fed the EPA-rich diet with the ﬁctitious surgery; EPA Sept: animals fed the
EPA-rich diet with the cecal ligation and puncture; GM: glutamate/malate; SR: succinate/rotenone; PM: palmitoylcarnitine/malate; state 3: state 3 respiration
rate (nmoles O2/min/mg of proteins); state 4: state 4 respiration rate (nmoles O2/min/mg of proteins); RCR: respiratory control ratio; ATP: rate of ATP
production (nmoles of ATP/min/mg of proteins); ATP : O: ratio between the production of ATP and the state 3 respiration rate (nmoles of ATP/nmoles of
O2); ROS state 3 and ROS state 4: H2O2 release during the state 3 and state 4 respirations (pmoles/min/mg of proteins); ROS/state 3: ratio between H2O2
release during state 3 and oxygen consumption during state 3 (pmoles of H2O2/nmoles of O2); ROS/state 4: ratio between H2O2 release during state 4 and
oxygen consumption during state 4 (pmoles of H2O2/nmoles of O2); ROS/ATP: ratio between H2O2 release during state 3 and rate of ATP production
(pmoles of H2O2/nmole of ATP); a, b, c: means without a common letter for the same parameter are signiﬁcantly diﬀerent.
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organ and isolated organelles. In the myocardial tissue
(Figure 6(i)), VDAC was increased by the EPA-rich diet
(+43% in general, p < 0 01). The increase in the Sham rats
was low (+8%, NS) but was more marked in the CLP group
(+87%, p < 0 01). The signiﬁcant cross-interaction indicated
that VDAC tended to be decreased by sepsis in the DEF
Table 6: Glycolytic enzyme mRNA expressions in the myocardium.
DEF Sham DEF Sept EPA Sham EPA Sept ANOVA
HK2 1 20 ± 0 12ab 1 69 ± 0 22a 1 03 ± 0 15ab 0 52 ± 0 05b D: p < 0 001CI: p < 0 01
PFK2 2 36 ± 0 28a 1 97 ± 0 22ab 2 35 ± 0 27a 1 38 ± 0 24b S: p < 0 05
PKm 0 94 ± 0 07a 0 80 ± 0 11ab 0 66 ± 0 10b 0 26 ± 0 03c D: p < 0 001S: p < 0 01
LDHM 0 91 ± 0 02a 0 98 ± 0 16a 0 87 ± 0 07a 0 55 ± 0 05b D: p < 0 05
LDHH 1 54 ± 0 16ab 1 76 ± 0 30b 1 10 ± 0 19a 0 44 ± 0 08c D: p < 0 001CI: p < 0 05
PDK4 0 68 ± 0 14a 0 52 ± 0 07ac 0 26 ± 0 06bc 0 06 ± 0 01b D: p < 0 001
The means represent the average of 8 rats. DEF Sham: rats fed the ω3 fatty acid-deﬁcient diet with ﬁctitious surgery; DEF Sept: rats fed the ω3 fatty
acid-deﬁcient diet with cecal ligation and puncture; EPA Sham: rats fed the EPA-rich diet with ﬁctitious surgery; EPA Sept: animals fed the EPA-rich diet
with the cecal ligation and puncture; HK2: hexokinase 2; PFK2: phosphofructokinase 2 inhibiting the phosphofructokinase 1; PKm: pyruvate kinase muscle
type; LDHM: muscular lactate dehydrogenase catalyzing the transformation of pyruvate to lactate; LDHH: cardiac lactate dehydrogenase catalyzing the
transformation of lactate to pyruvate; PDK4: pyruvate dehydrogenase kinase 4 inhibiting the pyruvate dehydrogenase by phosphorylation; ANOVA:
analysis of variance. The two-way analysis of variance describes the eﬀects of the diets (D), those of sepsis (S), and the cross-interaction between these two
factors (CI); a, b, c: means without a common letter for the same parameter are signiﬁcantly diﬀerent.
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Figure 2: Degree of acetylation of mitochondrial proteins: (a) representative immunoblots; (b) protein densitometry to Ponceau S of the
corresponding samples; (c) quantiﬁcation of protein acetylation. The means are the average of 8 rats. DEF: rats fed the ω3 polyunsaturated
fatty acid-deﬁcient diet; EPA: rats fed the eicosapentaenoic acid-enriched diet; Sham: sham-operated rats; Sept: septic rats; D: diet eﬀect;
CI: cross-interaction; A, B, C: histogram bars on the same panel without a common letter are signiﬁcantly diﬀerent.
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group (−20%, NS) but increased by the pathology in the EPA
group (+39%, p < 0 01).
In the isolated mitochondria, the VDAC content was not
aﬀected by the diets and the surgical procedures (data not
shown).
Since all these results suggest an increased mitochondrial
content in the septic myocardium of the EPA group, PGC-1α
protein expression was determined in the diﬀerent sub-
groups. The results indicated that the dietary and surgical
interventions did not modify the expression of this protein
(data not shown).
4. Discussion
This study set out to (i) determine whether the function
of cardiac mitochondria is prematurely modiﬁed—before
the occurrence of contractile dysfunctions—in early low-
severity sepsis induced by cecal ligation and puncture in rats
fed aWestern diet, (ii) ﬁnd out whether dietary eicosapentae-
noic acid (C20:5 n-3 or EPA) protects the integrity of these
organelles, and (iii) seek a potential mechanism responsible
for observed eﬀects. We found that the septic animals fed
the Western-type diet displayed a reduced mitochondrial
oxidative phosphorylation although the cardiac mechanical
function was not yet reduced. This was associated with an
increased mitochondrial oxidative stress. Dietary EPA exerts
cardioprotection against these changes through reducing the
mitochondrial oxidative stress, which may be related to
increased mitochondrial UCP3 and SIRT3 expressions.
4.1. Justiﬁcation of the Dietary Model. In the present study,
the inﬂuence of sepsis was studied in two diﬀerent popula-
tions of rats fed distinct dietary PUFAs. The ﬁrst population
was fed a diet in which the PUFAs were strictly ω6 (linoleic
acid). This diet was thus deﬁcient in ω3 PUFAs. It modeled
some features of the Western diet, which is characterized by
an excessive ingestion of ω6 PUFAs and an insuﬃcient ω3
PUFA intake. In industrialized societies, the ratio of dietary
ω6 PUFAs to ω3 PUFAs is around 15 but the World Health
Organization recommends a ratio close to 4–5. EPA, one of
the ω3 substrates of cyclooxygenase and lipoxygenase, was
thus added to the second diet.
Dietary EPA decreased ω6 PUFAs in cardiac phospho-
lipids, namely, arachidonic acid, C22:4ω6, and C22:5ω6,
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Figure 3: Cytoplasmic (SOD1) (a) and mitochondrial (SOD2) (b) superoxide dismutase mRNA expressions and mitochondrial SOD activity
(c) in female rats subjected to a 48 h sepsis. The means are the average of 8 rats. DEF: rats fed the ω3 polyunsaturated fatty acid-deﬁcient diet;
EPA: rats fed the eicosapentaenoic acid-enriched diet; Sham: sham-operated rats; Sept: septic rats; D: diet eﬀect; S: sepsis eﬀect; A, B:
histogram bars on the same panel without a common letter are signiﬁcantly diﬀerent; ∗signiﬁcantly diﬀerent by one-way analysis of variance.
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and increased long-chain ω3 PUFAs (C22:5 and C22:6ω3).
These modiﬁcations are classically observed when a ω6
PUFA-based diet is enriched with ω3 PUFAs [17, 18, 39].
The PUFA (ω6 + ω3) level of phospholipids is relatively
constant to maintain stability of the membrane ﬂuidity.
However, there is a perpetual renewal of acyl moieties in
the constitution of these complex lipids. It is due to the
activities of phospholipases A1 and A2 which deacylate the
phospholipids. The resulting lysophospholipids are immedi-
ately reacylated by lysophospholipid acyltransferases which
implant acyl moieties from acyl-CoA in these molecules.
PUFAS of the ω6 series and those of the ω3 family compete
for these enzymes. Introducing ω3 PUFAs in the diet thus
induces a decrease in ω6 PUFAs and an increase in ω3
PUFAS in cardiac membranes.
4.2. Limitations of the Study. The maximal sepsis duration
was 48h and the intensity of the microbial infection was
low (ligature at only 1 cm from the cecal apex). The sepsis
was limited to this severity (i) for the welfare of the animals
and to meet the requirements of the local ethics committee
on the use and care of laboratory animals and those of the
animal welfare cell of our laboratory and (ii) to limit animal
death and so have a suﬃcient sample size to validate statisti-
cal analysis. Clearly, the results obtained are restricted to this
short postsurgery period and low-severity sepsis and do not
allow extrapolation to other situations.
4.3. Eﬀects of the Diet and Surgical Procedure on Cardiac
Mechanical Function. Cardiac mechanical function was
estimated by MRI in the living animal anesthetized with
isoﬂurane. The proportion of isoﬂurane was strictly regu-
lated as a function of the respiratory rhythm. Body tem-
perature of the animals (37°C) was also strictly controlled
by adjusting the temperature of the gas ﬂow entering
the lungs.
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Figure 4: Degree of mitochondrial nitrosylated proteins: (a) representative immunoblots; (b) protein densitometry to Ponceau S of the
corresponding samples; (c) quantiﬁcation of mitochondrial nitrosylated proteins. The means are the average of 8 rats. DEF: rats fed the ω3
polyunsaturated fatty acid-deﬁcient diet; EPA: rats fed the eicosapentaenoic acid-enriched diet; Sham: sham-operated rats; Sept: septic
rats; CI: cross-interaction; A, B: histogram bars without a common letter are signiﬁcantly diﬀerent.
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Our model of sepsis had little eﬀect on cardiac morphol-
ogy and function. Sepsis has diﬀerent inﬂuences on cardiac
function according to the severity of the pathology: early sep-
sis increases the heart rate [6, 40] to ﬁght against the systemic
hypotension encountered in this situation [41]. With more
severe sepsis, diastolic dysfunctions occur [8]. Finally, with
evolution toward septic shock, systolic dysfunctions appear
[7]. The early low-severity sepsis induced in our study did
not trigger the expected increase in the heart rate occurring
in the hyperdynamic phase of the pathology. However, the
rate of contraction tended to be increased in both groups
(+13%, p = 0 08), suggesting a compensatory mechanism
for a probable hypotension. CLP in the rodent is known to
decrease body temperature [42]. In our study, the body tem-
perature was maintained at 37°C during the MRI measure-
ments. Since we increased the temperature artiﬁcially,
stimulation of the rate of contraction may have occurred
instead of the increased heart rate.
4.4. Eﬀects of the Diet and Surgical Procedure on
Mitochondrial Function. In the sham-operated rats, the
EPA-induced changes in the fatty acid composition of
membrane phospholipids aﬀected the cardiac mitochondria.
Oxidative phosphorylation was unchanged, but several fac-
tors related to the oxidative stress were altered. Nitrosylation
of mitochondrial proteins was decreased by EPA. This
decrease suggests attenuation of reactive oxygen species
(ROS) generation. Furthermore, the SOD2 mRNA expres-
sion tended to be decreased in this group (−40%, p = 0 13).
SOD2 is the mitochondrial enzyme, and the lowering of its
mRNA expression associated with the lower protein nitrosy-
lation suggests that ROS impregnation of the mitochondrial
matrix was reduced. The ω3 PUFA-related decrease in mito-
chondrial oxidative stress is of utmost importance in regulat-
ing the oxidative phosphorylation: ROS can block the Krebs
cycle by inhibiting aconitase [43]. EPA-induced reduction
of mitochondrial ROS impregnation can thus improve the
oxidative phosphorylation. The phenomenon was associated
with important changes in intermediary metabolism. Lysine
acetylation reﬂecting the intensity of the β-oxidation rate
[36] was decreased by the EPA diet, indicating a lower fatty
acid oxidation. Furthermore, the pyruvate dehydrogenase
kinase 4 mRNA expression was reduced by the ω3 PUFA.
Since this enzyme inhibits pyruvate dehydrogenase, this ﬁnd-
ing suggests that the oxidative decarboxylation of pyruvate to
acetyl-CoA in the mitochondrial matrix was accelerated.
Finally, dietary EPA seemed to shift substrate oxidation
toward a cardioprotective pattern characterized by high
glucose oxidation and low fatty acid degradation [34, 35].
Sepsis strongly depressed the oxidative phosphorylation
of cardiac mitochondria in the DEF-fed animals modeling
the human Western diet, although degradation of cardiac
mechanical function was not yet observed. Compensatory
energy production might have occurred through anaerobic
glycolysis. Abnormal mitochondrial activity was associated
with increased oxidative stress. This was ascertained by the
behavior of isolated mitochondria: they displayed an
increased ratio of H2O2 production to oxidative phosphory-
lation regardless of the substrate used. This indicates that
the ROS release was always higher at a similar rate of energy
production. The mitochondrial oxidative stress encountered
in the myocardium of these rats can explain the reduced oxi-
dative phosphorylation: ROS and calcium are recognized
eﬀectors of the mitochondrial permeability transition pore
(mPTP) [44]. The mPTP opening allows the release of
small-size water-soluble entities (MW< 1500Da) from the
mitochondrial matrix, namely, NADH and adenine nucleo-
tides, and this release reduces mitochondrial oxidative phos-
phorylation [17]. The sepsis-induced deﬁcit in mitochondrial
energy production translated into a reduction of mitochon-
drial protein acetylation reﬂecting a decreased β-oxidation
rate. Pyruvate oxidation was not increased in compensation
(unchanged glycolytic enzyme mRNA expressions). The
mitochondrial oxidative stress also explains the augmenta-
tion of IL-1β mRNA expression in the myocardium: inﬂam-
matory cytokine expression is favored by mitochondrial ROS
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and can trigger a mitochondrial oxidative stress in a vicious
cycle [45]. The cardiotoxicity after CLP was thus partly due
to inﬂammation, which probably resulted from the accumu-
lation of the proinﬂammatory ω6 PUFAs in membrane
phospholipids [23, 46].
In the animals fed the EPA-rich diet, the oxidative
phosphorylation of myocardial mitochondria was not
depressed by sepsis. As ascertained by the lower SOD2
mRNA expression and ROS release by isolated mitochondria,
the EPA-induced protection was due to a reduction of the
matrix oxidative stress. This situation allowed (i) mainte-
nance of the oxidative phosphorylation through prevention
of mPTP opening, (ii) upholding of the intensity of the
intermediate metabolism characterized by an increased
β-oxidation rate despite an apparent reduction of glycolysis
suggested by the decrease in gene expression of enzymes
directly involved in the glycolytic pathway (HK2 and PKm),
and (iii) a decrease in the inﬂammatory response character-
ized by a slackening of the NF-κB pathway and reduction of
IL-1β gene expression. This underlines the cardioprotective
eﬀects of EPA on sepsis, which is well documented in
the literature by numerous human studies [47–62].
VDAC is essential to maintaining a high rate of oxidative
phosphorylation, since the pore constituted by this protein
allows the inward and outward movements of solutes
through the outer mitochondrial membrane. Its expression
in the whole myocardium was increased by dietary EPA
in the septic subgroup, although it was unchanged in the
mitochondria. This suggests an increased mitochondrial
density. Yet PGC-1α was not overexpressed, indicating that
mitochondrial biogenesis was unchanged: it is thus proba-
ble that mitophagy was slackened by the lower oxidative
stress, leading to the progressive accumulation of nitrosy-
lated proteins. In the long term, this might be detrimental
for the heart and explain the few human studies describing
a lack of EPA-induced cardioprotection [62–64] or even a
negative eﬀect [65, 66].
4.5. Mechanisms of the Cardioprotective Eﬀects of
Dietary EPA
4.5.1. Dietary EPA in Sham-Operated Animals. Our study
shows that dietary EPA increased mitochondrial UCP3 con-
tent. Such an observation was already noticed in C2C12 cells
[67]. The reduced matrix oxidative stress of the EPA-
enriched heart was triggered by the observed increase in
mitochondrial UCP3 content [68]. UCP3 allows upholding
of the oxidative metabolism [69]: UCP3 expression facilitates
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matrix expulsion of fatty acids and reduces their degradation
in the β-oxidative pathway. Thus, a higher matrix-free CoA
content is available for pyruvate oxidation. The assumed
UCP3-related lower mitochondrial acyl-CoA content can
also account for the reduced matrix oxidative stress accumu-
lation of these toxic lipids in the mitochondria being known
to favor ROS production [70]. The phenomenon was associ-
ated with increased SIRT3 and decreased HIF-1 mRNA
expressions. Bell et al. [37] report in primary mouse embryo
ﬁbroblast that a decrease in the matrix oxidative stress
induces a reduction of HIF-1α expression. EPA reduced the
matrix oxidative stress and preconditioned the myocardium
in terms of mRNA expressions. When the mitochondrial
function was measured in the isolated organelles, no
change in mitochondrial function was observed except an
EPA-induced increase in the respiratory control ratio
(RCR) when palmitoylcarnitine/malate was used as a sub-
strate (+38%, p < 0 05). It is known that the UCP3-induced
reduction of the oxidative stress is related to lipid oxidation:
ROS open the mPTP and favor proton leakage [44], and this
decreases the RCR. The EPA-related ROS scavenging activity
improved the RCR, but the enhancement was limited to
the reactive oxygen species resulting from the β-oxidative
pathway. The changes in protein and/or gene expressions
seen in the myocardium of sham-operated animals proba-
bly constitute preconditioning allowing the EPA-induced
cardioprotection during sepsis.
4.5.2. Dietary EPA in Septic Animals. The lower oxidative
stress of the mitochondrial matrix of the EPA-fed rats was
maintained during sepsis. It allowed (i) the reduction of
inﬂammatory cytokine production, (ii) the maintenance of
the mPTP in a closed conﬁguration in the in vivo situation,
and (iii) the upholding of high rates of oxidative phosphory-
lation to sustain the cardiac mechanical function.
In this model of early sepsis, UCP3 expression was still
high in the cardiac mitochondria of animals treated with
EPA. This was associated with an increased protein nitrosyla-
tion. An UCP3-induced reduction of oxidative stress in favor
of an increased nitrosative stress has already been described
under conditions of high ROS production [38]. The reduc-
tion of the oxidative stress prevented the mPTP opening
and favored the upholding of the oxidative phosphorylation.
Our study shows for the ﬁrst time that the nitrosative stress is
less deleterious for the mitochondria than the oxidative stress
in these conditions of early sepsis. Furthermore, mitochon-
drial SIRT3 was also increased. Under stressing conditions,
this NAD+-dependent deacetylase is translocated into the
nucleus and mitochondria [71]. In the nucleus, the histone
deacetylase has been reported to limit NF-κB activation
[72]. It thus limits the inﬂammation process [73] and related
oxidative stress of the mitochondrial matrix. This eﬀect may
be potentiated by high expression of SIRT3 activating several
enzymes involved in ROS scavenging activity [74]. Moreover,
the increased protein acetylation observed in the septic
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mitochondria of the EPA group suggests stimulation of the
β-oxidative pathway. Protein acetylation has strong regula-
tory eﬀects on several mitochondrial enzymes [75]: it blocks
glucose and fatty acid oxidations through inhibition of pyru-
vate, very long-chain acyl-CoA, and long-chain acyl-CoA
dehydrogenases, but it stimulates enoyl-CoA hydratase/3-
hydroxyacyl-CoA dehydrogenase [76], potentially leading
to the accumulation of the amphiphilic and perhaps toxic
3-ketoacyl-CoA. By acting on a limited number of key
enzymes, SIRT3 is able to overcome these deleterious eﬀects
via deacetylation of the involved proteins [77]: it thus allows
the upholding of high rates of β-oxidation and oxidative
phosphorylation.
4.6. Conclusion (See Figure 7). Sepsis induces dysfunctions of
cardiac mitochondria before contractile abnormalities in rats
fed a Western-type diet. They are characterized by oxidative
stress and disruption of oxidative phosphorylation. Dietary
EPA and/or its elongation products (DPA and DHA) exert
a strong cardioprotective eﬀect, deﬁned by the absence or
delay of inﬂammation and upholding of the energy metabo-
lism in the physiological range. The reason for the ω3 PUFA-
induced anti-inﬂammatory eﬀect is a lowmitochondrial ROS
impregnation suspected to be related to increased UCP3 and
SIRT3 expressions. These eﬀects already emerge in the phys-
iological situation through changes in mRNA expressions
that precondition the myocardium. They can explain the
resistance to sepsis. The antioxidant eﬀect of n-3 PUFAs
has been regularly observed after short-term administration
(until 10 weeks) of these fatty acids [78–80]. However, Firuzi
et al. [81] noticed tendencies toward an increased circulating
8-iso-PGF2α concentration and decreased erythrocyte gluta-
thione peroxidase and catalase activities after a 6-month
treatment in patients enduring dilated cardiomyopathy. Fur-
ther investigations are thus necessary to determine whether
long-term administration of n-3 PUFAs has antioxidant
and anti-inﬂammatory properties. Moreover, future studies
with human cardiac mitochondria are now needed to con-
ﬁrm the protection observed in the rat during early sepsis.
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